Treatment of pompe's disease
AssigneesGenzyme Corporation, Pharming Intellectual Property B.V.
InventorsJohannes B.M.M. Van Bree, Edna H.G. Venneker, David P. Meeker
Life of this patent
Estimating the term…
Abstract
The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
Claims31
A method of treating a patient with Pompe's disease, comprising:
- administering to the patient a therapeutically effective amount of human acid alpha glucosidase.
A pharmaceutical composition comprising human acid alpha glucosidase, human serum albumin, and a sugar in a physiologically acceptable buffer in sterile form.
A pharmaceutical composition comprising alpha glucosidase, mannitol and sucrose in an aqueous solution.
A lyophilized composition produced by lyophilizing a pharmaceutical composition comprising human acid glucosidase, mannitol and sucrose in aqueous solution.
A pharmaceutical composition prepared by
- lyophilizing a first composition comprising human acid alpha-glucosidase, mannitol, sucrose and an aqueous solution to produce a second composition;
- and reconstituting the lyophilized composition in saline to produce a third composition.
Dependencies are inferred from the claim text.